4//SEC Filing
van den Broek Richard 4
Accession 0001169245-22-000060
CIK 0001169245other
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:44 PM ET
Size
8.0 KB
Accession
0001169245-22-000060
Insider Transaction Report
Form 4
van den Broek Richard
Director
Transactions
- Award
Non-employee Director Stock Option (right to buy)
2022-05-19+17,500→ 17,500 totalExercise: $0.84Exp: 2032-05-18→ Common Stock (17,500 underlying) - Award
Restricted Stock Units
2022-05-19+3,750→ 3,750 total→ Common Stock (3,750 underlying)
Footnotes (3)
- [F1]The shares subject to the option shall vest on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date.
- [F2]Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock.
- [F3]The RSUs shall vest and be delivered to the Reporting Person on the earlier of the one-year anniversary of the grant date or the 2023 annual stockholder meeting, subject to the Reporting Person's continuous service through such date.
Documents
Issuer
PhaseBio Pharmaceuticals Inc
CIK 0001169245
Entity typeother
Related Parties
1- filerCIK 0001431872
Filing Metadata
- Form type
- 4
- Filed
- May 19, 8:00 PM ET
- Accepted
- May 20, 4:44 PM ET
- Size
- 8.0 KB